Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Turkish experience with therapeutic plasma exchange: A national survey.
Korkmaz S, Solmaz Medeni S, Demirkan F, Kalayoglu Besisik S, Altay Dadin S, Akgun Cagliyan G, Kabukcu Hacioglu S, Sari I, Goren Sahin D, Arat M, Dagdas S, Ozet G, Kutlu N, Karaagac Akyol T, Ozcebe OI, Uskudar Teke H, Kiper Unal D, Guner N, Tombak A, Celik H, Bay I, Kiki I, Ozgur G, Erkurt MA, Ozatli D, Meletli O, Demircioglu S, Demir C, Kurtoglu E, Vural F, Tobu M, Karakus A, Ayyildiz O, Dal MS, Afacan Ozturk B, Albayrak M, Ocakci S, Bolaman Z, Sonmez M, Karakus V, Gokmen Sevindik O, Berber I, Dogu MH, Gulturk E, Ulas T, Payzin B, Kuku I, Cagirgan S, Altuntas F. Korkmaz S, et al. Among authors: gulturk e. Transfus Apher Sci. 2019 Jun;58(3):287-292. doi: 10.1016/j.transci.2019.04.015. Epub 2019 Apr 23. Transfus Apher Sci. 2019. PMID: 31036516
Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey.
Bakırtaş M, Dal MS, Yiğenoğlu TN, Giden AO, Serin I, Başcı S, Kalpakci Y, Korkmaz S, Ekinci O, Albayrak M, Basturk A, Ozatli D, Dogu MH, Hacıbekiroglu T, Çakar MK, Ulas T, Miskioglu M, Gulturk E, Eser B, Altuntas F. Bakırtaş M, et al. Among authors: gulturk e. J Chemother. 2023 Oct;35(6):563-569. doi: 10.1080/1120009X.2023.2208439. Epub 2023 May 21. J Chemother. 2023. PMID: 37211906
Bleomycin-Induced Flagellate Dermatitis.
Turan Erkek E, Karaali CN, Yılmaz G, Gültürk E. Turan Erkek E, et al. Among authors: gulturk e. Turk J Haematol. 2019 May 3;36(2):138-140. doi: 10.4274/tjh.galenos.2019.2018.0317. Epub 2019 Jan 2. Turk J Haematol. 2019. PMID: 30600679 Free PMC article. No abstract available.
Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia.
Tanrikulu Simsek E, Eskazan AE, Cengiz M, Ar MC, Ekizoglu S, Salihoglu A, Gulturk E, Elverdi T, Ongoren Aydin S, Senem Demiroz A, Buyru AN, Baslar Z, Ozbek U, Ferhanoglu B, Aydin Y, Tuzuner N, Soysal T. Tanrikulu Simsek E, et al. Among authors: gulturk e. J Clin Pathol. 2016 Sep;69(9):810-6. doi: 10.1136/jclinpath-2015-203320. Epub 2016 Jan 25. J Clin Pathol. 2016. PMID: 26811428
Bone marrow transplantation for Behçet's disease: a case report and systematic review of the literature.
Soysal T, Salihoğlu A, Esatoğlu SN, Gültürk E, Eşkazan AE, Hatemi G, Hatemi I, Öngören Aydın Ş, Erzin YZ, Başlar Z, Tüzüner N, Ferhanoğlu B, Çelik AF. Soysal T, et al. Among authors: gulturk e. Rheumatology (Oxford). 2014 Jun;53(6):1136-41. doi: 10.1093/rheumatology/ket479. Epub 2014 Feb 6. Rheumatology (Oxford). 2014. PMID: 24505123 Review.
Impact of COVID-19 on Outcomes of Patients with Hematologic Malignancies: A Multicenter, Retrospective Study.
Acar IH, Guner SI, Ak MA, Gocer M, Ozturk E, Atalay F, Sincan G, Yikilmaz AS, Ekinci O, Ince I, Gulturk E, Demir N, Dogan A, Ipek Y, Guvenc B. Acar IH, et al. Among authors: gulturk e. Mediterr J Hematol Infect Dis. 2022 Nov 1;14(1):e2022074. doi: 10.4084/MJHID.2022.074. eCollection 2022. Mediterr J Hematol Infect Dis. 2022. PMID: 36425152 Free PMC article.
22 results